FOXO Technologies Inc. (FOXO): Price to Sales

Low dependence on market cycles and the slow adoption of AI-driven risk assessment in insurance are driving price dynamics; viewing the chart on GURU.Markets, we observe that the revenue valuation metric 0.10 is hitting a new level. Strategically, FOXO Technologies (FOXO) relies on the B2B integration of epigenetic data into underwriting, however, high R&D costs coupled with a lack of profitability are creating a cash flow gap.

The P/S ratio compares market capitalization to sales volume, determining the premium paid per unit of revenue and assessing the asset's fundamental value. By analyzing the historical P/S trend on the GURU.Markets platform, an investor can identify capital freeze risks for FOXO Technologies (FOXO), whose micro-scale operations in AI epigenetics leave it vulnerable to expansion by tech behemoths.